Barrett's esophagus: What do we need to know?

Disease-a-month : DM
Nabeeha Mohy-Ud-DinSreeram Parupudi

Abstract

Barrett's esophagus (BE) is characterized by a change in the mucosal lining of the distal esophagus whereby the squamous epithelium of the esophagus is replaced by the metaplastic columnar epithelium. It is a pre-malignant lesion associated with esophageal adenocarcinoma. Patients with gastroesophageal reflux disease who have additional risk factors (Caucasian race, male gender, age > 50 years, tobacco use, and central obesity) should undergo an esophagogastroduodenoscopy to screen for Barrett's esophagus. Patients with Barrett's esophagus should undergo endoscopic surveillance every 3-5 years if no dysplasia is found. Patients with Barrett's esophagus who are found to have dysplasia should be treated endoscopically. We present a comprehensive review of the pathophysiology, diagnosis, surveillance and management of Barrett's esophagus.

Citations

Sep 11, 2020·Journal of Clinical Gastroenterology·Aun ShahRonnie Fass
Mar 1, 2021·Obesity Surgery·Matías OrellanaRodrigo Muñoz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Related Papers

La Revue du praticien
Zoé Richert, Michel Robaszkiewicz
JAMA : the Journal of the American Medical Association
Nicholas J Shaheen, David F Ransohoff
Annual Review of Medicine
B J Reid, W M Weinstein
Current Opinion in Gastroenterology
Giovanni Zaninotto, Christian Rizzetto
Mayo Clinic Proceedings
A J Cameron
© 2022 Meta ULC. All rights reserved